Literature DB >> 25843618

Innate immune evasion by filoviruses.

Christopher F Basler1.   

Abstract

Ebola viruses and Marburg viruses, members of the filovirus family, cause severe hemorrhagic fever. The ability of these viruses to potently counteract host innate immune responses is thought to be an important component of viral pathogenesis. Several mechanisms of filoviral innate immune evasion have been defined and are reviewed here. These mechanisms include suppression of type I interferon (IFN) production; inhibition of IFN-signaling and mechanisms that either prevent cell stress responses or allow the virus to replicate in the face of such responses. A greater understanding of these innate immune evasion mechanisms may suggest novel therapeutic approaches for these deadly pathogens.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ebola virus; Hemorrhagic fever; Innate immunity; Interferon; Marburg virus

Mesh:

Substances:

Year:  2015        PMID: 25843618      PMCID: PMC4424075          DOI: 10.1016/j.virol.2015.03.030

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  84 in total

1.  Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.

Authors:  Lawrence W Leung; Man-Seong Park; Osvaldo Martinez; Charalampos Valmas; Carolina B López; Christopher F Basler
Journal:  Immunol Cell Biol       Date:  2011-01-25       Impact factor: 5.126

2.  Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.

Authors:  Parameshwaran Ramanan; Megan R Edwards; Reed S Shabman; Daisy W Leung; Ariel C Endlich-Frazier; Dominika M Borek; Zbyszek Otwinowski; Gai Liu; Juyoung Huh; Christopher F Basler; Gaya K Amarasinghe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

3.  Upregulation of Nrf2 expression by human cytomegalovirus infection protects host cells from oxidative stress.

Authors:  Junsub Lee; Kyungmi Koh; Young-Eui Kim; Jin-Hyun Ahn; Sunyoung Kim
Journal:  J Gen Virol       Date:  2013-04-11       Impact factor: 3.891

4.  Stimulation of NF-κB activity by the HIV restriction factor BST2.

Authors:  Andrey Tokarev; Marissa Suarez; Wilson Kwan; Kathleen Fitzpatrick; Rajendra Singh; John Guatelli
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

5.  Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.

Authors:  Daisy W Leung; Kathleen C Prins; Dominika M Borek; Mina Farahbakhsh; JoAnn M Tufariello; Parameshwaran Ramanan; Jay C Nix; Luke A Helgeson; Zbyszek Otwinowski; Richard B Honzatko; Christopher F Basler; Gaya K Amarasinghe
Journal:  Nat Struct Mol Biol       Date:  2010-01-17       Impact factor: 15.369

6.  Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway.

Authors:  Dylan Burdette; Mathew Olivarez; Gulam Waris
Journal:  J Gen Virol       Date:  2009-11-04       Impact factor: 3.891

7.  Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection.

Authors:  Brian R Amman; Serena A Carroll; Zachary D Reed; Tara K Sealy; Stephen Balinandi; Robert Swanepoel; Alan Kemp; Bobbie Rae Erickson; James A Comer; Shelley Campbell; Deborah L Cannon; Marina L Khristova; Patrick Atimnedi; Christopher D Paddock; Rebekah J Kent Crockett; Timothy D Flietstra; Kelly L Warfield; Robert Unfer; Edward Katongole-Mbidde; Robert Downing; Jordan W Tappero; Sherif R Zaki; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol; Jonathan S Towner
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

8.  Marburg virus evades interferon responses by a mechanism distinct from ebola virus.

Authors:  Charalampos Valmas; Melanie N Grosch; Michael Schümann; Judith Olejnik; Osvaldo Martinez; Sonja M Best; Verena Krähling; Christopher F Basler; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

Review 9.  The antiviral activities of tetherin.

Authors:  Stuart J D Neil
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  An upstream open reading frame modulates ebola virus polymerase translation and virus replication.

Authors:  Reed S Shabman; Thomas Hoenen; Allison Groseth; Omar Jabado; Jennifer M Binning; Gaya K Amarasinghe; Heinz Feldmann; Christopher F Basler
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

View more
  15 in total

1.  The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.

Authors:  Constantin Brinkmann; Inga Nehlmeier; Kerstin Walendy-Gnirß; Julia Nehls; Mariana González Hernández; Markus Hoffmann; Xiangguo Qiu; Ayato Takada; Michael Schindler; Stefan Pöhlmann
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

2.  Therapeutic potential of the heme oxygenase-1 inducer hemin against Ebola virus infection.

Authors:  Hanxia Huang; Krishnamurthy Konduru; Veronica Solovena; Zhao-Hua Zhou; Namita Kumari; Kazuyo Takeda; Sergei Nekhai; Sina Bavari; Gerardo G Kaplan; Kenneth M Yamada; Subhash Dhawan
Journal:  Curr Trends Immunol       Date:  2016

Review 3.  Immunobiology of Ebola and Lassa virus infections.

Authors:  Joseph B Prescott; Andrea Marzi; David Safronetz; Shelly J Robertson; Heinz Feldmann; Sonja M Best
Journal:  Nat Rev Immunol       Date:  2017-01-23       Impact factor: 53.106

4.  TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction.

Authors:  Rui Pedro Galão; Harry Wilson; Kristina L Schierhorn; Franka Debeljak; Bianca S Bodmer; Daniel Goldhill; Thomas Hoenen; Sam J Wilson; Chad M Swanson; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2022-05-09       Impact factor: 6.823

5.  One Health: Addressing Global Challenges at the Nexus of Human, Animal, and Environmental Health.

Authors:  Waithaka Mwangi; Paul de Figueiredo; Michael F Criscitiello
Journal:  PLoS Pathog       Date:  2016-09-15       Impact factor: 6.823

6.  The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.

Authors:  Kari A Dilley; Alexander A Voorhies; Priya Luthra; Vinita Puri; Timothy B Stockwell; Hernan Lorenzi; Christopher F Basler; Reed S Shabman
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

7.  Insights into Reston virus spillovers and adaption from virus whole genome sequences.

Authors:  César G Albariño; Lisa Wiggleton Guerrero; Harley M Jenks; Ayan K Chakrabarti; Thomas G Ksiazek; Pierre E Rollin; Stuart T Nichol
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

Review 8.  The roles of ebolavirus glycoproteins in viral pathogenesis.

Authors:  Yun-Jia Ning; Fei Deng; Zhihong Hu; Hualin Wang
Journal:  Virol Sin       Date:  2016-11-14       Impact factor: 4.327

9.  Transcriptional analysis of viral mRNAs reveals common transcription patterns in cells infected by five different filoviruses.

Authors:  César G Albariño; Lisa Wiggleton Guerrero; Ayan K Chakrabarti; Stuart T Nichol
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

10.  Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease.

Authors:  Joanna Luczkowiak; Fatima Lasala; Marta Mora-Rillo; Jose R Arribas; Rafael Delgado
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.